How to Buy Anduril Stock Pre-IPO

Anduril was founded in 2017 by Palmer Luckey and Brian Schimpf (CEO) on the thesis that the U.S. defense industrial base was too slow, too dependent on legacy prime contractors, and structurally unable to adapt at the pace modern warfare requires. The product catalog covers drones, counter-drone interceptors, autonomous surveillance systems, radar, and missile engines — but the durable competitive position sits in the software layer.

Lattice OS is Anduril's battlefield operating system — it ingests data from drones, satellites, cameras, and ground sensors and fuses them into a real-time 3D command-and-control picture across every Anduril hardware product. If Lattice becomes the default integration layer for autonomous military systems across U.S. and allied forces, it creates the kind of software lock-in that defense primes have never had to contend with. That prospect is what underpins the $61 billion Series H valuation at $2.2 billion in annual revenue — a roughly 28x multiple that makes sense only if the software thesis is correct.

Revenue figures are reported estimates from Series H announcement disclosures and third-party reporting. All figures unaudited. 2026 revenue projection is management guidance reported by The Information, not confirmed financial results.

CEO Brian Schimpf stated in the Series H announcement that the funding "reflects growing investor confidence in defense technology companies as the U.S. and its allies address mounting technological and industrial challenges tied to military modernization and evolving security threats, including great-power competition, China's expanding influence and the rise of autonomous warfare." Schimpf added that Anduril will invest "aggressively" in manufacturing capacity, R&D, and infrastructure.

The manufacturing investment is the critical variable. Arsenal-1 is the Ohio facility intended for mass production of aerial and maritime drones, sensors, and other defense products. A separate Mississippi rocket motor factory is also in development. Both require sustained capital deployment before they reach unit economics that could support profitability — and profitability is the management-stated prerequisite for an IPO.

The January 2026 investor letter — which Anduril released publicly after U.S. operations involving Iran reinforced its thesis — discussed the "changing character of conflict" and the importance of resilient production capacity, rapid adaptation, and the ability to sustain operations during extended conflicts. That letter frames the Series H: this is a war materiel production scaling exercise, not a technology product R&D investment. The investor calculus is correspondingly different from the other names in this series.

Unlike software companies whose revenue is primarily recurring subscription revenue, Anduril's revenue is program-based: large government contracts with defined ceilings, multi-year terms, and delivery milestones. That structure provides meaningful forward visibility but also concentration risk — a program cancellation or budget cut can remove a material revenue line without warning.

Ceiling values represent maximum program value over full term; IDIQ contracts are task-order based and ceiling is only realized if all orders are issued. These contracts are publicly trackable through USAspending.gov and the DoD contract announcement database at defense.gov/News/Contracts. Sources: Anduril announcements, DoD contract databases, Reuters, TechCrunch. Not a complete contract list.

The Army enterprise IDIQ is the contract that makes the $4.3 billion 2026 projection credible. A $20 billion ceiling over 10 years implies $2 billion per year at full utilization — and Anduril's 2025 revenue of $2.2 billion already exceeds that average, suggesting the Army vehicle is supplemental to existing contract flow rather than the entire basis. That figure is the leading indicator to track against quarterly and annual disclosures before any IPO filing.

The adverse scenario is not Anduril fails — it is Anduril continues to grow, Arsenal-1 takes 18–24 months longer than the current capital deployment timeline implies, and the company raises a Series I in 2027 or 2028 at a higher nominal valuation but below the secondary market implied price that buyers are currently paying.

For secondary investors who bought at Forge's $112.73 (implying ~$84 billion), a Series I at $80–90 billion would represent a dilutive round below their effective entry. Ownership percentage compresses, the IPO timeline extends, and the secondary market reprices downward as the scarcity premium dissipates without a listing catalyst. That is dilution, duration, and price compression — simultaneously.

This scenario is not speculative — it is the base case if Arsenal-1 manufacturing takes longer than expected. Defense manufacturing is categorically different from software deployment: supply chain dependencies, labor constraints, tooling lead times, and government qualification requirements all create timeline risk that no amount of venture capital fully removes.

Every other company in this guide series has a primary structural constraint that investors need to understand before looking at price or platform. For Anthropic it is a void-transfer declaration. For Databricks it is a no-direct-transfer policy. For OpenAI it is board-level consent requirements. For Anduril, the constraint is both less formally declared and potentially more practically limiting: a defense company's management team has reasons to care about who owns equity in the business that have nothing to do with corporate governance and everything to do with national security considerations.

Hiive's own platform disclosure states: "most direct stock transfers must be approved by Anduril itself" and "some companies do not generally approve transfers of common shares." That language is not standard boilerplate — it is a specific disclosure about this company's transfer posture. Combined with the thin secondary supply evidence (25 live orders would be unusual for Anduril; the Hiive page shows limited active orders), the practical access picture is materially different from the Forge Price headline of $112.73.

ITAR — the International Traffic in Arms Regulations — governs Anduril's products, not its equity. Foreign nationals cannot own equity in ITAR-controlled companies under certain conditions, but standard accredited investor status and U.S. nationality do not trigger ITAR restrictions for share ownership. Where ITAR matters for secondary investors is in its downstream effect: a defense company that must manage what information it shares with shareholders has structural reasons to be selective about new cap-table entries that a software or fintech company simply does not have.

The IPO thesis for Anduril is more structurally dependent on operational milestones than any other company in this guide series. Luckey's statement that Anduril wants to be profitable before going public is not founder preference for privacy — it is a financial readiness condition. At current revenue scale and with ongoing heavy R&D and manufacturing investment, profitability is not imminent.

The $4.3 billion 2026 revenue projection — if achieved — would make the profitability case substantially more credible. At $4.3 billion in revenue on a software-augmented defense platform model, positive operating margins are achievable, particularly as Arsenal-1 manufacturing unit costs decline with scale. The Army enterprise contract vehicle with a ceiling of up to $20 billion over 10 years provides the revenue visibility that makes 2026 guidance credible.

The prediction market shift — from 46% to 19% probability of a 2026 IPO in March 2026 — preceded the Series H and reflected the market's assessment that another large private raise was more likely than an imminent listing. That assessment proved correct. Late 2026 or 2027 remains the analyst consensus window, but the conditions are explicit: profitability first, then market timing.

The standard accredited investor thresholds apply — income, net worth, or qualifying professional credentials. The investor suitability and accreditation reference covers the full requirements. For every other guide in this series, that is the end of the eligibility analysis. For Anduril, there is a second layer.

ITAR — the International Traffic in Arms Regulations — governs Anduril's products, not its equity. Standard accredited investor status does not trigger ITAR restrictions for U.S. persons acquiring shares. But a defense company that must manage what information it shares with shareholders has structural reasons to be selective about new cap-table entries that a software or fintech company simply does not have. Non-U.S. investors should seek qualified legal counsel before acquiring equity in any ITAR-registered defense company — the considerations are specific to jurisdiction, nationality, and the class of shares being acquired.

Unlike most names in this series, there is no publicly traded vehicle with a meaningful disclosed Anduril position. The public market comparables are structural — they expose the same defense technology sector dynamics, not Anduril equity directly.

Palantir is the most cited public analogue for Anduril's software-first defense thesis, and it trades publicly. The business models diverge significantly — Palantir is a data analytics and AI platform sold to both defense and commercial customers, while Anduril is a hardware-plus-software autonomous systems manufacturer focused almost exclusively on defense. But for retail investors who believe in the broader software-defined warfare thesis, Palantir is the clearest available proxy.